$10.760
+0.005 (+0.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DMAA Prediction & Forecast by Similar Chart Analysis
Alphio's DMAA stock price prediction model matches the current Drugs Made In America Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.83 (+0.69%). The 1-week path is $10.82 (+0.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Drugs Made In America Acquisition Corp Stock?
Currently, DMAA is not a strong buy due to its high P/E ratio of 55.63 and a low current ratio of 0.02, indicating potential liquidity issues. The RSI is at 61.24, suggesting it is nearing overbought territory, which may limit upside potential in the short term.
DMAA stock price ended at $10.76 on Wednesday, after rising +0.05%
Drugs Made In America Acquisition Corp (DMAA) last closed at $10.76, gaining +0.05%. These facts feed the 1-day and 1-week DMAA price prediction above.
Forecast Drivers
Drugs Made In America Acquisition Corp (DMAA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches DMAA, ranked by similarity.
Seasonality analysis for DMAA
Historically the probability of a positive September return for DMAA is 100.00%. April offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DMAA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $6.97 | $9.13 | $10.59 | -15.15% |
| Oct 2026 | $9.44 | $10.44 | $11.98 | -2.96% |
| Nov 2026 | $9.61 | $11.80 | $13.16 | +9.65% |
| Dec 2026 | $9.57 | $9.82 | $10.91 | -8.72% |
In 2026, Drugs Made In America Acquisition Corp (DMAA) is projected to range from $6.97 to $13.16.
Drugs Made In America Acquisition Corp 2026 monthly forecast
In Sep 2026, Drugs Made In America Acquisition Corp is projected to average $9.13, with a low of $6.97 and high of $10.59.
In Oct 2026, Drugs Made In America Acquisition Corp is projected to average $10.44, with a low of $9.44 and high of $11.98.
In Nov 2026, Drugs Made In America Acquisition Corp is projected to average $11.80, with a low of $9.61 and high of $13.16.
In Dec 2026, Drugs Made In America Acquisition Corp is projected to average $9.82, with a low of $9.57 and high of $10.91.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.